ES8700259A1 - Un procedimiento para la preparacion de (4s)-6-fluor-espiro (croman-4,4'-imidazolidin)-2',5'-diona o su (2r)-metil deri-vado - Google Patents

Un procedimiento para la preparacion de (4s)-6-fluor-espiro (croman-4,4'-imidazolidin)-2',5'-diona o su (2r)-metil deri-vado

Info

Publication number
ES8700259A1
ES8700259A1 ES546294A ES546294A ES8700259A1 ES 8700259 A1 ES8700259 A1 ES 8700259A1 ES 546294 A ES546294 A ES 546294A ES 546294 A ES546294 A ES 546294A ES 8700259 A1 ES8700259 A1 ES 8700259A1
Authority
ES
Spain
Prior art keywords
methyl
diona
preparation
compound
imidazolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546294A
Other languages
English (en)
Spanish (es)
Other versions
ES546294A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES8700259A1 publication Critical patent/ES8700259A1/es
Publication of ES546294A0 publication Critical patent/ES546294A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pens And Brushes (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Coloring (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cosmetics (AREA)
ES546294A 1984-08-20 1985-08-20 Un procedimiento para la preparacion de (4s)-6-fluor-espiro (croman-4,4'-imidazolidin)-2',5'-diona o su (2r)-metil deri-vado Expired ES8700259A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64200884A 1984-08-20 1984-08-20

Publications (2)

Publication Number Publication Date
ES8700259A1 true ES8700259A1 (es) 1986-10-01
ES546294A0 ES546294A0 (es) 1986-10-01

Family

ID=24574782

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546294A Expired ES8700259A1 (es) 1984-08-20 1985-08-20 Un procedimiento para la preparacion de (4s)-6-fluor-espiro (croman-4,4'-imidazolidin)-2',5'-diona o su (2r)-metil deri-vado

Country Status (22)

Country Link
US (1) US4716113A (en:Method)
EP (1) EP0172719B1 (en:Method)
JP (2) JPS6157588A (en:Method)
KR (1) KR870000628B1 (en:Method)
AT (1) ATE37371T1 (en:Method)
AU (1) AU556793B2 (en:Method)
DD (2) DD240207A5 (en:Method)
DE (1) DE3565105D1 (en:Method)
DK (1) DK374985A (en:Method)
EG (1) EG17060A (en:Method)
ES (1) ES8700259A1 (en:Method)
FI (1) FI853183A7 (en:Method)
GR (1) GR851993B (en:Method)
HU (3) HU194857B (en:Method)
IL (1) IL76131A (en:Method)
NO (1) NO853254L (en:Method)
NZ (1) NZ213128A (en:Method)
PH (1) PH26782A (en:Method)
PL (2) PL148572B1 (en:Method)
PT (1) PT80985B (en:Method)
YU (1) YU43879B (en:Method)
ZA (1) ZA856267B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
US5151544A (en) * 1990-05-25 1992-09-29 Alcon Laboratories, Inc. Intermediates in the preparation of chiral spirofluorenehydantoins
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
US5508466A (en) * 1994-04-13 1996-04-16 G.D. Searle & Co. Synthesis of N-protected-α-substituted-glycine racemic esters by zinc-mediated addition of organic halide to glycine cation equivalent
US9839701B2 (en) 2013-02-12 2017-12-12 Osaka University Aromatic amino acid derivative and positron emission topography (PET) probe using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878043A (en) * 1973-01-02 1975-04-15 Univ Southern Illinois Method for preparing L-dopa and novels compounds useful therein
DE2336718A1 (de) * 1973-07-19 1975-02-06 Basf Ag Verfahren zur herstellung von substituierten oxazolinon-(5)-verbindungen
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
DE2807286A1 (de) * 1978-02-21 1979-08-23 Bayer Ag Stereoselektive spaltung von phenylglycinderivaten und 4-hydroxyphenylglycinderivaten mit enzymharzen
US4267342A (en) * 1978-08-21 1981-05-12 Pfizer Inc. Spiro-oxazolidindiones
US4262092A (en) * 1979-05-08 1981-04-14 Ethyl Corporation Process for producing N-acyl-D-phenylalanine ester
DE2927534A1 (de) * 1979-07-07 1981-01-08 Bayer Ag Optisch reine heterocyclische aminosaeuren, verfahren zu ihrer herstellung und ihre verwendung
DE2927535A1 (de) * 1979-07-07 1981-01-08 Bayer Ag Stereoselektive spaltung von phenylglycinderivaten mit enzymharzen
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
GB2098212B (en) * 1981-05-12 1984-11-14 Ici Plc Process for preparing 1'-substituted-spiro(imidazolidine)-4,3'-indoline-2,2',5-triones
US4435578A (en) * 1982-11-10 1984-03-06 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives

Also Published As

Publication number Publication date
ATE37371T1 (de) 1988-10-15
HU201042B (en) 1990-09-28
ZA856267B (en) 1987-04-29
HU193127B (en) 1987-08-28
HUT39745A (en) 1986-10-29
PL148572B1 (en) 1989-10-31
IL76131A0 (en) 1985-12-31
YU43879B (en) 1989-12-31
GR851993B (en:Method) 1985-12-17
KR870002142A (ko) 1987-03-30
AU556793B2 (en) 1986-11-20
JPS6362512B2 (en:Method) 1988-12-02
FI853183L (fi) 1986-02-21
HUT43577A (en) 1987-11-30
JPS6157588A (ja) 1986-03-24
AU4641485A (en) 1986-02-27
NZ213128A (en) 1988-02-29
JPS63290873A (ja) 1988-11-28
PT80985B (pt) 1987-12-30
HUT46316A (en) 1988-10-28
PL255065A1 (en) 1986-11-04
PH26782A (en) 1992-10-13
FI853183A0 (fi) 1985-08-19
EP0172719A1 (en) 1986-02-26
US4716113A (en) 1987-12-29
DK374985D0 (da) 1985-08-19
DD254005A5 (de) 1988-02-10
KR870000628B1 (ko) 1987-03-26
PL260564A1 (en) 1987-02-09
DE3565105D1 (en) 1988-10-27
HU194857B (en) 1988-03-28
NO853254L (no) 1986-02-21
ES546294A0 (es) 1986-10-01
DD240207A5 (de) 1986-10-22
EP0172719B1 (en) 1988-09-21
FI853183A7 (fi) 1986-02-21
PL147253B1 (en) 1989-05-31
PT80985A (en) 1985-09-01
YU131985A (en) 1988-04-30
EG17060A (en) 1991-03-30
IL76131A (en) 1989-01-31
DK374985A (da) 1986-02-21

Similar Documents

Publication Publication Date Title
EA200100457A1 (ru) Способ получения циталопрама
FI931680A0 (fi) Foerbaettrat foerfarande foer syntetisering av (4r-cis)-1,1-dimetyletyl-6-cyanometyl-2,2-dimetyl-1,3-dioxan-4-acetat
EA199900580A1 (ru) Фармацевтические производные аминофосфоновой кислоты
ES2068364T3 (es) Procedimiento de preparacion de (met)acrilato de alquilimidazolidona.
ES8700259A1 (es) Un procedimiento para la preparacion de (4s)-6-fluor-espiro (croman-4,4'-imidazolidin)-2',5'-diona o su (2r)-metil deri-vado
MX9403286A (es) Acido valerico substituido.
FR2392989A1 (fr) Nouveaux phenyl-benzimidazolyl-furannes, leur procede de preparation et leur utilisation comme azurants optiques des matieres organiques
ES2026150T3 (es) Procedimiento para la obtencion de gamma-butirolactonas alfa-substituidas.
CO4700282A1 (es) Compuestos
ES2074148T3 (es) Nueva substancia anticancer antibiotica, su produccion y sus usos.
ATE9225T1 (de) Derivate des 5-hydroxy-tetrahydro-2-furanons.
SE7908994L (sv) Tiazolidin- och pyrrolidinderivat
ES2054480T3 (es) Nuevos sustratos de enzimas, analogos de acidos grasos.
ES2053572T3 (es) Procedimiento para la separacion enzimatica de los isomeros opticos de derivados oxazolidinonicos.
GB1424416A (en) Prostaglandin intermediates and their preparation
IE33679B1 (en) 3-(3,4-dihydroxyphenyl)-alanine
ES399873A1 (es) Procedimiento para la preparacion de nuevos i-fenoxi-2- idroxi-3-alcahilamino propanos recemicos u opticamenacti- vos.
DK0678518T3 (da) Fremgangsmåde til fremstilling af mellemprodukter til syntesen af glucose-6-phosphatase-inhibitorer samt nye mellemprodukte
DE59010041D1 (de) Herstellung von Dioxolanderivaten
ES502947A0 (es) Procedimiento para la obtencion de esteres de acido dimeta- crilico
ATE53001T1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten, sowie von d-alphatocopherol.
FR2382901A1 (en:Method)
ES8707167A1 (es) Un procedimiento para producir treo-3-(3,4-metilendioxifenil) serina opticamente activa
ATE46315T1 (de) Verfahren zur herstellung optisch aktiver chinonderivate.
ES2105596T3 (es) Procedimiento para la preparacion de un acido oxazolidina-1,3-carboxilico-5.